Total Reports
210
FDA CVM filings
Dog /
FDA CVM · 2025 release 210 reports on file
Coonhound - Redbone - FDA Adverse Event Profile
Adverse-event records for Coonhound - Redbone (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Coonhound - Redbone ranks #182 by report volume among dog breeds - 8 of 210 reports (3.8%) recorded a death outcome.
- #182
- most-reported dog breed
- 3.8%
- death-coded report share
- 32
- Lack of efficacy (endoparasite) - heartworm - top reaction
- 4.7 yr
- average age at report
Report counts track breed popularity and reporting activity, not real-world risk, read this alongside how common the breed is.
Deaths Reported
8
of 210 reports
Death Rate
3.8%
death-coded share
Avg Age at Report
4.7 yr
30.1 kg avg weight
Death-Coded Outcome Share
Coonhound - Redbone death-coded reports 3.8%
Cross-breed median
3.8% of 210 coonhound - redbone reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 30.1 kg (66.4 lbs)
Top Reported Reactions
Lack of efficacy (endoparasite) - heartworm 32
Vomiting 24
Lack of efficacy (endoparasite) - hookworm 20
INEFFECTIVE, HEARTWORM LARVAE 17
Emesis 14
Lethargy (see also Central nervous system depression in 'Neurological') 14
Diarrhoea 13
Decreased appetite 10
Most Referenced Drugs
Milbemycin Oxime + Spinosad 45
Milbemycin Oxime + Praziquantel 33
Pyrantel Pamoate;Sarolaner 31
Moxidectin 22
Ivermectin + Pyrantel As Pamoate Salt 20
Oclacitinib Maleate 11
Fluralaner 13.64% 12-Week Chew 9
Afoxolaner 8
Outcome Breakdown
Ongoing
83 (39.5%)
Outcome Unknown
59 (28.1%)
Recovered/Normal
48 (22.9%)
Recovered with Sequela
12 (5.7%)
Died
4 (1.9%)
Euthanized
4 (1.9%)
Gender Distribution
Female 108 (51.4%)
Male 100 (47.6%)
Unknown 2 (1.0%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2012 | 5 | |
| 2013 | 12 | |
| 2014 | 13 | |
| 2015 | 7 | |
| 2016 | 11 | |
| 2017 | 20 | |
| 2018 | 8 | |
| 2019 | 12 | |
| 2020 | 12 | |
| 2021 | 21 | |
| 2022 | 16 | |
| 2023 | 34 | |
| 2024 | 28 | |
| 2025 | 11 | |
Coonhound - Redbone Pet Health Insights
Coonhound - Redbone accounts for 210 FDA adverse event reports, ranking #182 by volume among dog breeds, with 8 reports (3.8%) coded as a death outcome. Mean age at report: 4.7 years, average weight 30.1 kg (66.4 lbs).
Top reported signs: Lack of efficacy (endoparasite) - heartworm (32), Vomiting (24), Lack of efficacy (endoparasite) - hookworm (20). Most-referenced drug: Milbemycin Oxime + Spinosad (45 reports), followed by Milbemycin Oxime + Praziquantel (33) and Pyrantel Pamoate;Sarolaner (31).
Outcome coding on 210 status-recorded reports is dominated by Ongoing (39.5%). Annual submissions ranged 2,012-2,025 across 14 years on file.
Dog Breeds With a Similar Report Volume
Treeing Feist
215 reports · 1.9% death rate
Griffon - French Wire-haired Pointing
218 reports · 0.5% death rate
Spaniel - Tibetan
219 reports · 5.0% death rate
Terrier - American Staffordshire
197 reports · 2.0% death rate
Setter - Gordon
227 reports · 5.3% death rate
Terrier - Norwich
232 reports · 3.0% death rate
Frequently Asked Questions
How many FDA adverse event reports involve Coonhound - Redbone? ▼
There are 210 adverse event reports involving Coonhound - Redbone in the FDA database, with 8 reports involving death (3.8% death rate). Coonhound - Redbone ranks #182 by report volume.
What are the most common adverse reactions reported for Coonhound - Redbone? ▼
The most commonly reported adverse reactions for Coonhound - Redbone are Lack of efficacy (endoparasite) - heartworm (32 reports), Vomiting (24 reports), Lack of efficacy (endoparasite) - hookworm (20 reports), INEFFECTIVE, HEARTWORM LARVAE (17 reports), Emesis (14 reports).
What drugs are most frequently associated with Coonhound - Redbone adverse events? ▼
The drugs most frequently referenced in Coonhound - Redbone adverse event reports are Milbemycin Oxime + Spinosad (45 reports), Milbemycin Oxime + Praziquantel (33 reports), Pyrantel Pamoate;Sarolaner (31 reports), Moxidectin (22 reports), Ivermectin + Pyrantel As Pamoate Salt (20 reports).
What is the average age of Coonhound - Redbone in adverse event reports? ▼
The average age of Coonhound - Redbone at the time of adverse event reports is 4.7 years, with an average weight of 30.1 kg (66.4 lbs).
Does a high number of adverse event reports mean Coonhound - Redbone is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Coonhound - Redbone safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.